E-LIB Suche - Ergebnisse für: Hutchings, M

1

A RCT to explore the effectiveness of supporting adherence ..:

Bradley, J. M. ; Hutchings, M. ; Arden, M. A....
BMC Pulmonary Medicine. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

EARLY FDG‐PET ADAPTED TREATMENT OF LIMITED STAGE HODGKIN LY..:

Federico, M. ; Fortpied, C. ; Stepanishyna, Y....
Hematological Oncology. 41 (2023) S2 - p. 159-160 , 2023

Link: https://doi.org/10.1002/..

3

LOW MORTALITY FROM COVID‐19 IN PATIENTS WITH B CELL LYMPHOM..:

Kyvsgaard, E. R. ; Riley, C. ; Clausen, M. R....
Hematological Oncology. 41 (2023) S2 - p. 814-815 , 2023

Link: https://doi.org/10.1002/..

4

Enhanced ctDNA Profiling Reveals Molecular Determinants of ..:

Meriranta, L. ; Kolstad, A. ; Hutchings, M....
Hematological Oncology. 41 (2023) S2 - p. 477-478 , 2023

Link: https://doi.org/10.1002/..

5

Glofitamab plus immunochemotherapy demonstrates durable eff..:

Townsend, W. ; Topp, M. S. ; Dickinson, M....
Hematological Oncology. 41 (2023) S2 - p. 595-597 , 2023

Link: https://doi.org/10.1002/..

6

SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REM..:

Thieblemont, C. ; Karimi, Y. ; Jurczak, W....
Hematological Oncology. 41 (2023) S2 - p. 142-144 , 2023

Link: https://doi.org/10.1002/..

7

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RE..:

Hutchings, M. ; Avigdor, A. ; Sureda, A....
Hematological Oncology. 41 (2023) S2 - p. 138-140 , 2023

Link: https://doi.org/10.1002/..

8

P147 "What options are available for those not able to take..:

Daniels, T. ; Lai, L.Y. ; Cameron, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S110 , 2023

Link: https://doi.org/10.1016/..

9

SOLUBLE MACROPHAGE MARKER SCD163 PREDICTS OUTCOME IN BOTH C..:

Nikkarinen, A. ; Lokhande, L. ; Amini, R....
Hematological Oncology. 41 (2023) S2 - p. 746-748 , 2023

Link: https://doi.org/10.1002/..

10

P207 CFHealthHub allows clinicians to identify people with ..:

Sandler, R.D. ; Lai, L. ; Anderson, A....
Journal of Cystic Fibrosis. 22 (2023) - p. S128 , 2023

Link: https://doi.org/10.1016/..

11

COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE A..:

Hutchings, M. ; Dickinson, M. ; Carlo‐Stella, C....
Hematological Oncology. 41 (2023) S2 - p. 136-138 , 2023

Link: https://doi.org/10.1002/..

12

P378 The value of a community of practice, within the CFHea..:

Daniels, T. ; Hutchings, M. ; Dawson, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S179-S180 , 2023

Link: https://doi.org/10.1016/..

13

GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY..:

Dickinson, M. ; Carlo‐Stella, C. ; Morschhauser, F....
Hematological Oncology. 41 (2023) S2 - p. 144-146 , 2023

Link: https://doi.org/10.1002/..

14

The experiences and needs of unpaid family caregivers for p..:

Campbell-Enns, Heather J. ; Bornstein, Stephen ; Hutchings, Veronica M. M....
PLOS ONE. 18 (2023) 6 - p. e0286548 , 2023

Link: https://doi.org/10.1371/..

15

GLOFITAMAB MONOTHERAPY INDUCES DURABLE COMPLETE REMISSIONS ..:

Carlo‐Stella, C. ; Hutchings, M. ; Offner, F....
Hematological Oncology. 41 (2023) S2 - p. 63-65 , 2023

Link: https://doi.org/10.1002/..